Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain

Conclusion: Combined impedance-pH monitoring identifies different subtypes of NCCP patients who can receive tailored management. Targeted therapy with PPIs and/or citalopram offers complete symptom relief in the great majority of them.
Source: European Journal of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Original Articles: Gastro-esophageal Disorders Source Type: research